VIM and head and neck squamous cell carcinoma: One miRNA targeting VIM was identified and found to be downregulated in exosomes from HNSCC patients compared to HD (Supplementary Figure 2), which fits the observation of higher vimentin protein and mRNA levels with exosomes from before therapy in vitro.